Another CpG locus in our study with significantly increased levels of DNA methylation in the MetS patients compared to the control subjects was located in the FTO gene, while another locus in this gene was tending towards a significant difference between the control group and the T2D patients. This evidence concerns the gene FTO and type 2 diabetes mellitus.